drugset / Trial / NCT06361823
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to investigate the safety and efficacy of semaglutide in patients with Idiopathic intracranial hypertension.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2024-12-01
- Completion
- 2025-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 1 mg | Subcutaneous |